U.S. market Closed. Opens in 5 hours 20 minutes

AKYA | Akoya Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue96.63M74.86M54.92M42.44M42.24M
Cost of Revenue48.40M31.47M20.70M16.54M17.57M
Gross Profit48.24M43.39M34.22M25.91M24.66M
Operating Expenses104.27M109.60M71.44M37.40M38.17M
Selling, General & Admin82.38M79.65M51.02M23.98M26.35M
Research & Development21.89M23.21M15.70M9.60M8.76M
Other Operating Expenses-343.00K6.73M4.73M3.81M3.06M
Operating Income-56.03M-66.21M-37.23M-11.49M-13.50M
Other Expenses / Income-7.25M-4.31M-5.85M-5.17M-1.05M
Before Tax Income-63.28M-70.52M-43.08M-16.66M-14.56M
Income Tax Expenses40.00K123.00K-140.00K42.00K194.00K
Net Income-63.32M-70.64M-42.94M-16.71M-14.75M
Interest Expenses8.76M4.55M3.12M2.72M1.88M
Basic Shares Outstanding44.43M37.75M37.42M37.11M37.11M
Diluted Shares Outstanding44.43M37.75M37.42M37.11M37.11M
EBITDA-47.14M-59.33M-32.91M-7.64M-10.82M
EBITDA Margin-48.78%-79.26%-59.92%-18.00%-25.62%
EBIT-54.52M-65.96M-39.96M-13.94M-12.68M
EBIT Margin-56.42%-88.12%-72.76%-32.85%-30.01%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙